Ten Years Retrospective Study about Helicobacter pylori Eradication Rate.
10.7704/kjhugr.2015.15.2.112
- Author:
Gyung Won JEONG
1
;
In Kyung SUNG
Author Information
1. Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea. 20050051@kuh.ac.kr
- Publication Type:Original Article
- Keywords:
Helicobacter pylori;
Standard triple therapy;
Eradication rate
- MeSH:
Amoxicillin;
Anti-Bacterial Agents;
Breath Tests;
Clarithromycin;
Drug Resistance, Microbial;
Helicobacter pylori*;
Humans;
Peptic Ulcer;
Proton Pumps;
Retrospective Studies*;
Treatment Failure;
Urea
- From:The Korean Journal of Helicobacter and Upper Gastrointestinal Research
2015;15(2):112-116
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND/AIMS: Eradication of Helicobacter pylori is a main treatment of peptic ulcer disease. A triple therapy comprised of a proton pump inhibitor, clarithromycin, and amoxicillin is the most commonly used treatment for H. pylori eradication. The eradication of H. pylori infection requires combination of antibiotics. However, development of antibiotic resistance is a major cause of treatment failure. MATERIALS AND METHODS: This study was to observe H. pyrori eradication rate change for 10 years. From August 2005 to June 2014, a total of 4,891 patients with H. pylori infection were treated with standard H. pylori triple eradication therapy (proton pump inhibitor, amoxicillin, clarithromycin) and were analyzed by urea breath test. RESULTS: The overall rates of eradication with standard triple therapy was 82.8% (4,048/4,891). H. pylori eradication rates decreased from 92.2% in 2005 to 80.2% in 2014 (P=0.037). CONCLUSIONS: This study shows that the overall rate of H. pylori eradication with standard triple therapy decreased meaningfully for 10 years.
